These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17955899)

  • 1. Seroprevalence and risk factors for infection with West Nile virus in Saskatchewan horses, 2003.
    Epp T; Waldner C; Leighton FA; Berke O; Townsend HG
    Can J Vet Res; 2007 Oct; 71(4):256-63. PubMed ID: 17955899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
    Epp T; Waldner C; Townsend HG
    Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of West Nile virus in feral horses on Sheldon National Wildlife Refuge, Nevada, United States.
    Franson JC; Hofmeister EK; Collins GH; Dusek RJ
    Am J Trop Med Hyg; 2011 Apr; 84(4):637-40. PubMed ID: 21460023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of West Nile virus in Iran.
    Chinikar S; Shah-Hosseini N; Mostafavi E; Moradi M; Khakifirouz S; Jalali T; Goya MM; Shirzadi MR; Zainali M; Fooks AR
    Vector Borne Zoonotic Dis; 2013 Aug; 13(8):586-9. PubMed ID: 23697768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine seroprevalence of West Nile virus antibodies in the UK in 2019.
    Folly AJ; Waller ESL; McCracken F; McElhinney LM; Roberts H; Johnson N
    Parasit Vectors; 2020 Nov; 13(1):596. PubMed ID: 33243297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses.
    Ward MP; Levy M; Thacker HL; Ash M; Norman SK; Moore GE; Webb PW
    J Am Vet Med Assoc; 2004 Jul; 225(1):84-9. PubMed ID: 15239478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Nile virus infection in horses in Jordan: clinical cases, seroprevalence and risk factors.
    Abutarbush SM; Al-Majali AM
    Transbound Emerg Dis; 2014 Aug; 61 Suppl 1():1-6. PubMed ID: 24393369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. West Nile seroprevalence study in Bolivian horses, 2011.
    Mazzei M; Savini G; Di Gennaro A; Macchioni F; Prati MC; Guzmàn LR; Tolari F
    Vector Borne Zoonotic Dis; 2013 Dec; 13(12):894-6. PubMed ID: 24107210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factors associated with positive IgM capture ELISA results in equids with clinical signs compatible with West Nile virus infection: 1,017 cases (2003).
    Tanner JM; Traub-Dargatz JL; Hill AE; Van Campen H; Knight AP; Cunningham WE; Salman MD
    J Am Vet Med Assoc; 2006 Feb; 228(3):414-21. PubMed ID: 16448369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological Survey of West Nile Virus Infections in Horses from Berlin/Brandenburg and North Rhine-Westphalia, Germany.
    Bergmann F; Trachsel DS; Stoeckle SD; Bernis Sierra J; Lübke S; Groschup MH; Gehlen H; Ziegler U
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for antibodies to West Nile virus in Ireland.
    Raleigh PJ; Sammin DJ; Connell J; Markey BK; O'Connor M
    Vet Rec; 2012 Feb; 170(7):180. PubMed ID: 22238203
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive risk mapping of West Nile virus (WNV) infection in Saskatchewan horses.
    Epp TY; Waldner C; Berke O
    Can J Vet Res; 2011 Jul; 75(3):161-70. PubMed ID: 22210991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
    Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
    Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental risk factors of West Nile virus infection of horses in the Senegal River basin.
    Chevalier V; Dupressoir A; Tran A; Diop OM; Gottland C; Diallo M; Etter E; Ndiaye M; Grosbois V; Dia M; Gaidet N; Sall AA; Soti V; Niang M
    Epidemiol Infect; 2010 Nov; 138(11):1601-9. PubMed ID: 20175940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.